BIOLAB FARMACÊUTICA
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

BIOLAB FARMACÊUTICA Trademark

Serial Number: 86966146

BIOLAB FARMACÊUTICA is a trademark filed by BIOLAB SANUS FARMACÊUTICA LTDA. on April 6, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

BIOLAB SANUS FARMACÊUTICA LTDA. (7 trademarks)

Avenida Paulo Ayres, 280, Vila Iasi
São Paulo 06767-220 , BR

Entity Type: 16

Trademark Details

Filing Date

April 6, 2016

Registration Date

Not Registered

Goods & Services

Medicines for human and veterinary use in the treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; adjuvants for medical purposes; pharmaceutical preparations for human and veterinary use for the treatment and prevention of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; chemical-pharmaceutical preparations for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; nutritional complements in the nature of nutritional supplements; mineral food supplements; vitamins and mineral supplements; dietetic food, namely, cereals, powdered milk for babies, salt, and sugar adapted for medical use

Commercialization of pharmaceutical products in the nature of products for use in human and veterinary treatment for disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; nutritional supplements; mineral food supplements; vitamins and mineral supplements; dietetic foods, namely, cereals, powdered milk for babies, salt, and sugar adapted for medical use

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 2, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 1, 2017 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 28, 2017 GNFN
FINAL REFUSAL E-MAILED
Feb 28, 2017 GNFR
FINAL REFUSAL WRITTEN
Feb 28, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 1, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2016 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2016 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2016 CNRT
ASSIGNED TO EXAMINER
Jul 21, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Apr 12, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 11, 2016 NWOS
NEW APPLICATION ENTERED
Apr 9, 2016 NWAP